In Vitro Effects of Some Flavones on Human Pyruvate Kinase Isoenzyme M2

Journal of Biochemical and Molecular Toxicology

Volumn 29, Issue 3, 2015, Pages 109-113

  Aslan, Erdem ^a   Adem, Sevki ^a  

^a CANKIRI KARATEKIN UNIVERSITY   (Turkey)

Author keywords

Activation; Cancer; Flavone; Inhibition; PKM2

Indexed keywords

3 HYDROXYFLAVONE; APIGENIN; BAICALEIN; BAICALIN; DIOSMETIN; ENZYME ACTIVATOR; ENZYME INHIBITOR; FLAVONE; FLAVONE DERIVATIVE; LUTEOLIN; PHOSPHOENOLPYRUVATE; PYRUVATE KINASE; PYRUVATE KINASE M2; SCUTELLARIN; TANGERITIN; UNCLASSIFIED DRUG; WOGONIN; CARRIER PROTEIN; FLAVANONE DERIVATIVE; GLUCURONIC ACID; ISOENZYME; MEMBRANE PROTEIN; THYROID HORMONE; THYROID HORMONE-BINDING PROTEINS;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IC50; IN VITRO STUDY; DRUG EFFECTS; KINETICS; METABOLISM;

CARRIER PROTEINS; ENZYME ACTIVATORS; ENZYME INHIBITORS; FLAVANONES; FLAVONES; GLUCURONATES; HUMANS; ISOENZYMES; KINETICS; MEMBRANE PROTEINS; THYROID HORMONES;

EID: 84923922031     PISSN: 10956670     EISSN: 10990461     Source Type: Journal    
DOI: 10.1002/jbt.21673     Document Type: Article

References (21)

1. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008;452(7184):181-186.
2. Boxer MB, Jiang JK, Vander Heiden MG, Shen M, Skoumbourdis AP, Southall N, Veith H, Leister W, Austin CP, Park HW, Inglese J, Cantley LC, Auld DS, Thomas CJ. Evaluation of thieno[3, 2-b]pyrrole[3, 2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorg Med Chem Lett 2010;20(11):3387-3393.
3. Herling A, König M, Bulik S, Holzhütter HG. Enzymatic features of the glucose metabolism in tumor cells. FEBS J 2011;278(14):2436-2459.
4. Mazurek S. Pyruvate kinase M2: a key enzyme of the tumor metabolome and its medical relevance. Biomed Res 2012;23(special issue):133-142.
5. Porporato PE, Dhup S, Dadhich RK, Copetti T, Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2011;2:49.
6. Tamada M, Suematsu M, Saya H. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells. Clinical Cancer Res 2012;18(20):5554-5561.
7. Dykes L, Rooney LW. Phenolic compounds in cereal grains and their health benefits. Cereal Foods World 2007;52(3):105-111.
8. Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000;52(4):673-751.
9. Adem S, Comakli V, Kuzu M, Demirdag R. Investigation of the effects of some phenolic compounds on the activities of glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase from human erythrocytes. J Biochem Mol Toxicoldoi:10.1002/jbt.21592.
10. Singh M, Kaur M, Silakari O. Flavones: an important scaffold for medicinal chemistry. Eur J Med Chem 2014;84:206-239.
11. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008;452(7184):230-233.
12. Wong N, De Melo J, Tang D. PKM2, a central point of regulation in cancer metabolism. Int J Cell Biol 2013;2013:242513.
13. Granchi C, Minutolo F. Anticancer agents that counteract tumor glycolysis. ChemMedChem 2012;7(8):1318-1350.
14. Xu Y, Liu XH, Saunders M, Pearce S, Foulks JM, Parnell KM, Clifford A, Nix RN, Bullough J, Hendrickson TF and others. Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2). Bioorg Med Chem Lett 2014;24(2):515-519.
15. Chen J, Xie J, Jiang Z, Wang B, Wang Y, Hu X. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2. Oncogene 2011;30(42):4297-4306.
16. Ravishankar D, Rajora AK, Greco F, Osborn HMI. Flavonoids as prospective compounds for anti-cancer therapy. Int J Biochem Cell Biol 2013;45(12):2821-2831.
17. Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001;90(2-3):157-177.
18. Li-Weber M. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treatment Rev 2009;35(1):57-68.
19. Hirano T, Abe K, Gotoh M, Oka K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 1995;72(6):1380-1388.
20. Hirschhaeuser F, Sattler UGA, Mueller-Klieser W. Lactate: A metabolic key player in cancer. Cancer Research 2011;71(22):6921-6925.
21. Gupta V, Bamezai RN. Human pyruvate kinase M2: a multifunctional protein. Protein Sci 2010;19(11):2031-2044.